Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The global bioabsorbable stent market is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX % during the forecast period 2017-2022.Various factors which are driving the market growth is growing geriatric population susceptible to coronary and artery diseases, increased focus of clinics on trials of bioabsorbable stents, increased adoption of these stents by doctors and physicians, growing healthcare expenditure demands,obesity-related risks of cardiovascular disorders and preference for minimally invasive therapies.
However few factors hindering the growth of the bioabsorbable stent market is slow adoption rate and stringent government regulations. Other factors include slow approval by FDA for stents under trial, less commercial availability of stents as well as cost is a major factor impacting the slow growth and recognition of the bioabsorbable stent market.
Market Segmentation
The market is segmented in terms of material, absorption rate, applications and end user. By material, the market can be segmented into Bioresorbable polymer-based stents and Bioresorbable metallic stents. By absorption rate, it can be segmented into slow-absorption stents and fast-absorption stents. By application, it can be divided into coronary artery diseases and peripheral artery diseases. By end users, it can be segmented into hospitals and cardiac centers.
Regional/Geographical Analysis
Europe is expected to hold the largest shares by 2025 in the bioabsorbable stent market. On the other hand, the fastest growing market for the bioabsorbable stents is anticipated to be Asia-Pacific. North America is expected to grow at the highest CAGR of XX% during the forecast period. Followed by Asia Pacific excluding Japan (APEJ).
Key Players
Some of the major players in the market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...